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esponsibility of InstAbstract Asiatic acid (AA), a pentacyclic triterpene found in Centella asiatica, displays signiﬁcant anti-
proliferative effects on cancer cells in vitro although the underlying mechanism of this effect remains
unknown. This study investigated the efﬁcacy and mechanism of action of AA against lung cancer both
in vivo and in vitro. Using the MTT assay, AA was found to induce apoptosis in a dose- and time-
dependent manner, an effect enhanced by pretreatment with an autophagy inhibitor. It also elevated
expression of microtubule-associated protein 1 light chain 3 (LC3) and decreased the expression of p62.
Furthermore, exposure to AA resulted in collapse of the mitochondrial membrane potential and generation
of reactive oxygen species (ROS), suggesting mitochondria are the target of AA. In the mouse lung cancer
xenograft model, oral administration of AA signiﬁcantly inhibited tumor volume and weight accompanied
by signiﬁcant apoptosis of lung cancer cells. In addition, it led to a signiﬁcant decrease in the expression
of proliferating cell nuclear antigen (PCNA). In summary, the results show that AA signiﬁcantly reduces
lung cancer cell growth both in vitro and in vivo and that the associated apoptosis is mediated through
mitochondrial damage.
& 2017 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical
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Lung cancer is associated with high morbidity and mortality to
such an extent that in 2014 it was the leading cause of death
among all cancer patients in the United States1. In fact, in that
year, an estimated 221,200 cases of lung cancer were diagnosed
and 158,040 people died from the disease1. Although there have
been advances in our knowledge of the biology of the disease and
treatment options for lung cancer have increased, nevertheless the
5-year relative survival remains low at currently only 18%1. In the
case of non-small cell lung cancer (NSCLC), drugs targeting
epidermal growth factor receptor (EGFR), such as geﬁtinib and
erlotinib2–6, have been approved but their efﬁcacy is limited and
more than 50% of NSCLC patients are not suitable to receive
them5,7. Therefore, lung cancer remains a public health challenge
and novel anticancer drugs are needed.
Asiatic acid (AA) is a triterpene extracted from Centella
asiatica (L.) Urban (Umbelliferae) that has a long history of
successful use in both traditional Chinese and Indian Ayurvedic
medicine. Previous studies have demonstrated that AA exhibits a
variety of pharmacological effects not only as an antioxidant,
antiinﬂammatory and neuroprotective agent8–11, but also against
cancer. For example, AA induces apoptosis in human SK-MEL-2
melanoma cells by triggering generation of reactive oxygen
species (ROS)12 and does the same thing in HepG2 human
hepatoma cells by releasing intracellular Ca2þ and enhancing
expression of p5313. In addition, AA activates extracellular signal-
regulated kinase and p38 mitogen-activated protein kinase path-
ways and induces human breast cancer apoptosis and cell cycle
arrest14. While these in vitro data testify to the anti-cancer efﬁcacy
of AA, evidence from in vivo studies is limited. How
ever, it has been shown to prevent 9,10-dimethylbenz[a]anthra-
cene (DMBA)-initiated and 12-O-tetradecanoylphorbol-13-acetate
(TPA)-promoted mouse skin tumorigenesis by inhibiting NO and
COX-2 signaling15.
In the present study, we evaluated the effects of AA on lung
cancer cells in vitro and in the mouse Lewis lung cancer xenograft
model in vivo. As part of the work, we attempted to clarify the
mechanism of AA-induced apoptosis and its efﬁcacy against
lung cancer2. Materials and methods
2.1. Materials
Materials (suppliers) were as follows: AA, N-acetylcysteine (NAC),
chloroquine (CQ) and 3-methyladenine (3-MA, Sigma–Aldrich); 3-
[4,5-dimethyl-2-thiazolyl]-2,5-diphenyl-2H-tetrazolium bromide (MTT,
Amresco); JC-1 (5,50,6,60-tetrachloro-1,10,3,30-tetraethylbenzimidazo-
lylcarbocyanine iodide), Dulbecco's modiﬁed Eagle's medium
(DMEM) and Roswell Park Memorial Institute (RPMI)-1640 medium
(Life Technology, Waltham, MA, USA); annexin V/propidium iodide
(PI) kits for apoptosis, transferase-mediated deoxyuridine triphosphate-
biotin nick end labeling (TUNEL) assay kit and DCFH-DA kit
(Beyotime Institute of Biotechnology, Nantong, China); antibodies
against peroxisome proliferator-activated receptor (PARP), cytochrome
c, caspase-3, caspase-9, cytochrome oxidase subunit IV (COXIV),
LC3 and p62 (Cell Signaling Technology, Boston, MA, USA); β-actin
and proliferating cell nuclear antigen (PCNA, Santa Cruz Biotechnol-
ogy, Santa Cruz, CA, USA). All other chemicals were of high purity
and purchased from commercial sources.2.2. Cell culture
Human A549 and H1299 lung cancer cell lines and mouse Lewis
lung cancer (LLC) cells were purchased from the Shanghai
Institute of Cell Biology, Shanghai, China. Cells were maintained
in DMEM medium supplemented with 10% (v/v) heat-inactivated
fetal bovine serum and antibiotics (100 U/mL penicillin and
100 U/mL streptomycin) at 37 1C in a humidiﬁed atmosphere of
5% CO2 (Thermo Fisher Scientiﬁc, MA, USA).
2.3. Animals
C57BL/6J mice (6–8 weeks old) were purchased from the
Shanghai Laboratory Animal Center, Shanghai, China. Brieﬂy,
mice were housed in plastic cages at 2172 1C on a 12 h light–
dark cycle with free access to pellet food and water. Animal
welfare and experimental procedures were carried out in strict
accordance with the Guide for the Care and Use of Laboratory
Animals (Ministry of Science and Technology of China, 2006) and
related ethical regulations of Nanjing University. All efforts were
made to minimize animal suffering and to reduce the number of
animals used.
2.4. MTT assay
Cells were plated at a density of approximately 4 103 cells/well
in 96-well plates and treated with various concentrations of AA in
triplicate. After incubation for various times, the MTT assay was
applied to determine cell viability using a 96-well plate reader
(Spectra MAX 190, Molecular Devices Corporation, CA, USA).
2.5. Cell apoptosis and cell cycle assay
Into 6-well plates 1 105 A549 cells were seeded and subse-
quently treated with AA (20, 40 and 80 mol/L) for up to 24 h.
Cells were then stained with 4ʹ,6-diamidino-2-phenylindole
(DAPI) and the nuclei photographed. In another experiment, cells
were collected, washed with PBS, stained with annexin V/PI in
binding buffer at room temperature for 15 min in the dark and then
analyzed by ﬂuorescence activated cell sorting (FACS) using a
Calibur ﬂow cytometer (Becton Dickinson, NJ, USA). annexin
Vþ/PI and annexin Vþ/PIþ cells were considered to be in the
early and late phases of apoptosis. To examine the cell cycle, cells
were collected, washed with PBS and then suspended in 1 mL
DNA staining solution (20 mg/mL of PI and 100 mg/mL of
RnaseA in PBS) for 30 min on ice. DNA content was analyzed
by FACS (Becton Dickinson, USA) and the resulting DNA
histograms quantiﬁed using Cell Quest Pro software.
2.6. Western blot analysis
Proteins were extracted in lysis buffer (30 mmol/L Tris pH 7.5,
150 mmol/L sodium chloride, 1 mmol/L phenylmethylsulfonyl
ﬂuoride, 1 mmol/L sodium orthovanadate, 1% Nonidet P-40,
10% glycerol and phosphatase and protease inhibitors), separated
by SDS-PAGE and electrophoretically transferred onto polyviny-
lidene ﬂuoride membranes. The membranes were probed with
antibodies overnight at 4 1C and then incubated with a horse radish
peroxidase-coupled secondary antibody. Detection was performed
using the LumiGLO chemiluminescent substrate system (KPL,
Gaithersburg, MD, USA).
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To determine mitochondrial membrane potential, A549 cells were
washed with PBS and incubated with 5 μg/mL JC-1 at 37 1C for
30 min. Cells were then washed twice with PBS and immediately
examined by ﬂuorescence spectrometry using a ﬂuorescence micro-
plate reader (Spectra MaxGemini, Molecular Devices Corporation,
USA). A 488 nm ﬁlter was used for excitation of JC-1 and emissions
at 535 and 595 nm were used to quantify the population of
mitochondria with green (JC-1 monomers) and red (JC-1 aggregates)
ﬂuorescence respectively. The red/green ratio was used to reﬂect the
mitochondrial membrane potential.
2.8. Intracellular ROS
The intracellular generation of ROS was analyzed using DCFH-DA
(2ʹ,7ʹ-dichlorodihydroﬂuorescein diacetate) as a probe. Cells were
incubated with 10 mmol/L DCFH-DA at 37 1C for 15 min. Then
DCFH-DA ﬂuorescence distribution of 1 104 cells was measured
using the ﬂuorescence microplate reader (Spectra MaxGemini, Mole-
cular Devices Corporation, USA) at excitation and emission wave-
lengths of 488 and 535 nm, respectively.
2.9. In vivo tumor growth assay
LLC cells were cultured, collected by centrifugation (1000 rpm, 5 min,
Eppendorf 5424R, Hamburg, Germany) and washed twice with ice-
cold PBS. They were then diluted to 1 107 cells/mL with PBS and
0.1 mL injected subcutaneously into the right ﬂanks of female
C57BL6/J mice (6–8 weeks of age). All mice formed tumors 3 days
after injection. Mice were subsequently distributed into 4 groups
(n¼8) according to tumor volume and vehicle and AA (50 and
100 mg/kg) administered (i.g.) to each mouse every day from day 0.
Tumor length and width were measured with a vernier caliper every
3 days and tumor volume calculated using the equation:Figure 1 Asiatic acid inhibits lung cancer cell proliferation. (A) Structur
various concentrations of asiatic acid. (B) Photographs showing morpholo
assay every 24 h. Data represent mean7SD of three different experimentsVolume¼ a b2=2 ð1Þ
where a is the maximal width and b is maximal orthogonal length.
On the 13th day, mice were weighed, euthanized and the tumors
removed and weighed.
2.10. Immunohistochemistry
Parafﬁn-embedded tumor sections were stained with a 1:400 dilution
of PCNA primary antibody. Detection was performed using the Real
Statistic Analysis Envision Detection kit. The images were collected by
microscopy (BX51TRF, Olympus).
2.11. TUNEL assay
Parafﬁn-embedded tumor sections were stained with TUNEL-FITC
(1:100) and then counter-stained with DAPI for 5 min. Images were
acquired using a Confocal Laser-Scanning Microscope (Olympus
FV1000).
2.12. Statistical analysis
Comparisons were made by one-way analysis of variance (ANOVA).
Differences were considered to be signiﬁcant when Po0.05. All
experiments were carried out in triplicate.3. Results
3.1. Anti-lung cancer cell growth activity
AA inhibited A549, H1299 and LLC cell proliferation in both a
dose- and time-dependent way (Fig. 1A and C). Photographs of
cells (Fig. 1B) shows that, compared to the adherent and spindle-e of asiatic acid; (B) and (C) A549, H1299 and LLC cells exposed to
gical changes in cells; (C) Cell proliferation determined by the MTT
.
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and assumed a circular morphology.3.2. Apoptosis
A549 cells treated with AA for 24 h and then stained with DAPI
showed that nuclei became condensed and divided into several parts
with the emergence of apoptotic bodies (Fig. 2A). Other treated cells
stained with annexin V/PI showed the number of annexin Vþcells was
markedly increased from 17.1% to 54.5% (at 40 μmol/L) and to 63.9%
(at 80 μmol/L). To determine the involvement of the caspase cascade
in AA-induced apoptosis, the expression of caspases was examined by
Western blot. It was found that the hallmarks of apoptosis (PARP,Figure 2 Asiatic acid induces apoptotic cell death and cell cycle arrest in
and 80 μmol/L) for 24 h, stained with DAPI and nuclei photographed. (B
annexin V/PI analysis (B). Data represent mean7SEM of three different
Figure 3 Asiatic acid induces apoptotic cell death via a mitochondrial pat
for 3, 6, 12, 24 h or 20, 40, 80 μmol/L for 12 h) after which PARP, casp
release level of cytochrome c from mitochondria was examined by Westecaspase-9 and caspase-3) were activated/cleaved in A549 cells treated
with AA in a dose- and time-dependent manner (Fig. 3A and B). In
addition, cytochrome c was transferred from the mitochondrial
intermembrane to the cytoplasm (Fig. 3C). These results support the
view that AA induces signiﬁcant apoptosis in A549 cells.3.3. Mitochondrial dysfunction
As mitochondria are critical for apoptosis, it was logical to explore the
effect of AA on mitochondrial function. Using JC-1 to evaluate the
mitochondrial membrane potential, it was found that treatment with 20,
40, and 80 μmol/L AA for 12 h led to mitochondrial membrane
potential collapse as shown by enhanced green intensity, reduced redlung cancer cells. (A) A549 cells were treated with asiatic acid (20, 40
) A549 cells treated with asiatic acid were collected and subjected to
experiments.
hway. (A) and (B) A549 cells were exposed to asiatic acid (80 μmol/L
ase-9 and caspase-3 activation was assessed by Western blot. (C) The
rn blotting.
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dependent manner (Fig. 4B and C). Intracellular ROS was then
assessed by DCFH-DA ﬂorescence and found to be signiﬁcantly
elevated by AA treatment again in a dose- and time-dependant manner.
To determine the role of ROS in AA-induced apoptosis, weFigure 4 Asiatic acid treatment causes mitochondrial dysfunction. (A)–(C
or 20, 40, 80 μmol/L for 12 h) and the mitochondrial membrane pote
ﬂuorescence microscopy and quantiﬁed by ﬂuorescence spectrometry. (D) a
12 h) and the level of ROS detected by DCFH-DA staining. (F) A549 cells
without NAC (2.5 mmol/L) for 48 h. The MTT assay was used to evaluate
*Po0.05, **Po0.01 vs. control.investigated whether inhibition of ROS by NAC affected A549
cell death. As shown in Fig. 4F, the MTT assay revealed that
apoptosis induced by AA was markedly reduced by NAC. Thus the
results indicate that AA triggers mitochondrial dysfunction and
ROS-dependent cell death in A549 cells.) A549 cells were exposed to asiatic acid (80 μmol/L for 3, 6, 12, 24 h
ntial (JC-1 staining, red/green ﬂuorescence ratio) photographed by
nd (E) A549 cells were exposed to asiatic acid (20, 40, 80 μmol/L for
were exposed to asiatic acid (20, 40 and 80 μmol/L for 12 h) with or
cell viability. Data represent mean7SD of three different experiments.
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As mitochondrial damage is also critical for autophagy, it was
appropriate to examine whether autophagic cell death contributes to
the cytotoxic effects of AA. This possibility was analyzed by seeking
evidence that LC3-I (19 kD) is converted to the preautophagosomal
and autophagosomal membrane-bound form of LC3-II (17 kD) (a
speciﬁc marker for autophagosome formation). As shown in Fig. 5, theFigure 5 Asiatic acid induces cell protective autophagy. (A) and (B) A5
80 μmol/L for 6, 12, 24 h) and protein expression of LC3 and p62 analyz
concentrations of asiatic acid for 24 h with or without 3-MA and CQ pretre
are mean7SD of three different experiments. *Po0.05, **Po0.01 vs. ind
Figure 6 Asiatic acid inhibits tumor growth in vivo. 1 106 LLC cells w
days after transplantation, mice were randomly allocated to either control o
(A) and (B) Tumor volume and mouse bodyweight were recorded daily. Af
spleen index was calculated. (E) Parafﬁn sections of tumor tissues from mi
density was calculated. Scale bar, 50 μm. Data represent mean7SEM, n¼formation of LC3-labeled vacuoles was markedly increased in A549
cells after treatment with 80 μmol/L AA for 12 h. LC3-I to LC3-II
conversion markedly increased with time and concentration of AA as
shown by Western blot (Fig. 5A and B).
To establish whether autophagy is associated with cell death,
the effect of autophagy inhibitors was examined. It was found
using the MTT assay that pretreatment with the autophagy
inhibitor 3-MA or the autophagolysosome fusion inhibitor CQ49 cells were treated with asiatic acid (20, 40, 80 μmol/L for 12 h or
ed by Western blot. (C) and (D) A549 cells were treated with various
atment (2 h). The MTT assay was used to evaluate cell viability. Data
icated.
ere transplanted subcutaneously into the armpit of the C57 mice. Three
r treatment groups (n¼6). Drugs were administered i.g. on days 1–13.
ter sacriﬁce, solid tumors were separated and weighed. (C) and (D) The
ce were analyzed by H&E staining and TUNEL staining and (F) optical
8, *Po0.05, **Po0.01 vs. control.
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manner (Fig. 5C and D). These results support the premise that
autophagy protects A549 cells from AA-induced cell death.
3.5. In vivo anticancer activity
In the mouse xenograft model of LLC cells in C57BL/6J mice, once
daily administration of AA (50 and 100 mg/kg) inhibited tumor
growth in a dose-dependent manner (Fig. 6A and C). The tumor
inhibition rate at 100 mg/kg was 54%. 5-Fluorouracil (5FU) signiﬁ-
cantly reduced the bodyweight and spleen index in mice whereas no
signiﬁcant change was observed in AA-treated mice (Fig. 6B and D).
According to ex vivo results, both the TUNEL assay and PCNA
staining of tumor tissue from mice proved that proliferation of tumor
cells was inhibited and that tumor cells were undergoing signiﬁcant
apoptosis after AA treatment (Fig. 6E and F). In summary, the results
show that AA can effectively suppress tumor growth in vivo with no
signiﬁcant side effects.4. Discussion
In the present study, we evaluated the effects of AA on lung cancer
cell lines and clariﬁed the mechanism of these effects. Our results
show that AA is able to inhibit cell proliferation and cause cell death
both in vitro and in vivo. In addition, we conﬁrmed that AA can induce
apoptosis mainly through interference with the mitochondrial mem-
brane potential which stimulates the release of cytochrome c and
triggers caspase signaling pathways and PARP activation which in turn
lead to apoptotic cell death.
It is well established that mitochondria and ROS play a central role
in the process of cell death, including apoptosis and autophagy16–18.
Under excessive oxidative stress, the accumulation of ROS reaches a
threshold level which triggers the opening of mitochondrial perme-
ability transition pores (MPTPs) or oxidation of mitochondrial outer
membranes. This in turn leads to the simultaneous collapse of the
mitochondrial membrane potential (ΔΨm) and a transient increase in
ROS generation by the respiratory chains that transform O2 to
ATP19,20. With the increase in mitochondrial permeability, the released
proteins and ROS play many roles in cellular processes including
DNA damage, activation of signaling pathways and activation of
transcription factors leading to upregulation of genes21. Consistent with
these observations, AA induces mitochondrial dysfunction including
matrix metalloproteinase (MMP) collapse subsequent to ROS accu-
mulation (Fig. 4).
Apoptosis type I is characterized by nuclear condensation and
fragmentation, apoptotic body emergence without plasma membrane
breakdown. During apoptosis, many death signals converge on
mitochondria, especially the release of cytochrome c due to the
increased permeability of the outer mitochondrial membrane and,
coordinately, the activation of downstream caspase signaling22. We
observed AA-induced activations of PARP, caspase-9 and caspase-3
and the disruption of the mitochondrial membrane potential indicating
that mitochondria are involved in AA-induced cell death (Figs. 2 and 3).
As type II cell death, autophagy may play an important role in
cancer cell death induced by chemotherapy. Autophagy is a dynamic
process involving autophagic ﬂux whereby autophagosomes are
stimulated to form, engulf cellular contents, fuse with lysosomes and
bring about the degradation of the contents23. Autophagy has both a
positive and negative face. On one hand, it is seen as a physiological
process that plays a protective role when cells encounter environmental
stress such as starvation or pathogen infection24. On the other hand,excess autophagy can act as a pro-death mechanism25. In A549 cells,
AA treatment led to elevation of the ratio of LC3-II to LC3-I indicating
the occurrence of autophagy. In addition, when combined with
autophagy inhibitors such as 3-MA and CQ, AA-induced cell death
was elevated. These results suggest that autophagy plays a protective
role during AA treatment (Fig. 5) as it does during exposure to many
other chemicals26–29. In this situation, suppression of this protective
autophagy is important to potentiate chemotherapies30.
In conclusion, the present study provides further evidence that
AA is a promising anticancer agent with the ability to induce
apoptosis mainly through a mitochondrion-mediated pathway.
Thus AA alone or in combination with autophagy inhibitors or
chemotherapeutic agents may represent a new option in the
treatment of lung cancer.
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